{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:48:50Z","timestamp":1767707330877,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00117","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T05:08:10Z","timestamp":1550552890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy"],"prefix":"10.3389","volume":"10","author":[{"given":"Po-Yin","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandar S.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Horlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Kiriazis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1084\/jem.185.1.111","article-title":"The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.","volume":"185","author":"Aiuti","year":"1997","journal-title":"J. Exp. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.113.02883","article-title":"Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.","volume":"63","author":"Amador","year":"2014","journal-title":"Hypertension"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141408","article-title":"Circulating stromal cell-derived factor 1alpha levels in heart failure: a matter of proper sampling.","volume":"10","author":"Baerts","year":"2015","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00059-003-2524-6","article-title":"Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.","volume":"28","author":"Brilla","year":"2003","journal-title":"Herz"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/art.34394","article-title":"CXCR4 and vascular cell adhesion molecule 1 are key chemokine\/adhesion receptors in the migration of cytokine-activated T cells.","volume":"64","author":"Bryant","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2.","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cvr\/cvu264","article-title":"Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators.","volume":"105","author":"Cartledge","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.2353\/ajpath.2010.090574","article-title":"Bone marrow-derived cells contribute to fibrosis in the chronically failing heart.","volume":"176","author":"Chu","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/CIRCHEARTFAILURE.110.960831","article-title":"CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess.","volume":"4","author":"Chu","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"B10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/CIRCIMAGING.113.001073","article-title":"Interstitial fibrosis, left ventricular remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: the Multi-Ethnic Study of Atherosclerosis (MESA) study.","volume":"7","author":"Donekal","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jacc.2013.10.084","article-title":"Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness.","volume":"63","author":"Ellims","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1152\/physrev.00008.2011","article-title":"Matricellular proteins in cardiac adaptation and disease.","volume":"92","author":"Frangogiannis","year":"2012","journal-title":"Physiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1161\/CIRCRESAHA.114.302530","article-title":"Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair.","volume":"114","author":"Furtado","year":"2014","journal-title":"Circ. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10741-013-9405-8","article-title":"Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.","volume":"19","author":"Glezeva","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.cardfail.2014.07.010","article-title":"Causes of exercise intolerance in heart failure with preserved ejection fraction: searching for consensus.","volume":"20","author":"Houstis","year":"2014","journal-title":"J. Card. Fail."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3727\/096368914X681739","article-title":"CXCR4 antagonist TG-0054 mobilizes mesenchymal stem cells, attenuates inflammation, and preserves cardiac systolic function in a porcine model of myocardial infarction.","volume":"24","author":"Hsu","year":"2015","journal-title":"Cell Transplant."},{"key":"B17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.","volume":"57","author":"Iles","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.jacc.2008.06.049","article-title":"Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.","volume":"52","author":"Iles","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/HYPERTENSIONAHA.118.11666","article-title":"Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation.","volume":"72","author":"Jackson","year":"2018","journal-title":"Hypertension"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007253","article-title":"SDF-1alpha (Stromal Cell-Derived Factor 1alpha) induces cardiac fibroblasts, renal microvascular smooth muscle cells, and glomerular mesangial cells to proliferate, cause hypertrophy, and produce collagen.","volume":"6","author":"Jackson","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/jmri.24515","article-title":"Assessment of myocardial partition coefficient of gadolinium (lambda) in dilated cardiomyopathy and its impact on segmental and global systolic function.","volume":"40","author":"Jacquier","year":"2014","journal-title":"J. Magn. Reson. Imaging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1161\/CIRCULATIONAHA.112.099242","article-title":"CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia\/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.","volume":"127","author":"Jujo","year":"2013","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ijcard.2015.10.126","article-title":"Macrophages dictate the progression and manifestation of hypertensive heart disease.","volume":"203","author":"Kain","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1097\/HJH.0b013e328349c62d","article-title":"CD4CD25Foxp3 regulatory T cells suppress cardiac fibrosis in the hypertensive heart.","volume":"29","author":"Kanellakis","year":"2011","journal-title":"J. Hypertens."},{"key":"B25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/eurheartj\/ehm003","article-title":"Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.","volume":"28","author":"Kelly","year":"2007","journal-title":"Eur. Heart J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/CIRCHEARTFAILURE.109.898916","article-title":"A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility.","volume":"3","author":"Kitzman","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"B27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/jcp.22322","article-title":"The origin of fibroblasts and mechanism of cardiac fibrosis.","volume":"225","author":"Krenning","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"C1799","DOI":"10.1152\/ajpcell.00166.2006","article-title":"Cardiac fibroblasts influence cardiomyocyte phenotype in vitro.","volume":"292","author":"LaFramboise","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1161\/CIRCULATIONAHA.113.007101","article-title":"CD4+ T cells promote the transition from hypertrophy to heart failure during chronic pressure overload.","volume":"129","author":"Laroumanie","year":"2014","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"B31","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction.","volume":"56","author":"Maeder","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCIMAGING.113.000633","article-title":"Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.","volume":"6","author":"Mascherbauer","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"B33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease.","volume":"8","author":"Moon","year":"2006","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"B34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/cimm.2001.1890","article-title":"Stimulation of T-Cell activation by CXCL12\/stromal cell derived factor-1 involves a G-protein mediated signaling pathway.","volume":"214","author":"Nanki","year":"2001","journal-title":"Cell Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225","article-title":"Left ventricular T-cell recruitment contributes to the pathogenesis of heart failure.","volume":"8","author":"Nevers","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"B36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jchf.2017.12.016","article-title":"Worsening heart failure during the use of DPP-4 inhibitors: pathophysiological mechanisms, clinical risks, and potential influence of concomitant antidiabetic medications.","volume":"6","author":"Packer","year":"2018","journal-title":"JACC Heart Fail."},{"key":"B37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1126\/science.283.5403.845","article-title":"Dependence of human stem cell engraftment and repopulation of NOD\/SCID mice on CXCR4.","volume":"283","author":"Peled","year":"1999","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1161\/CIRCRESAHA.116.307974","article-title":"T1 mapping in characterizing myocardial disease: a comprehensive review.","volume":"119","author":"Puntmann","year":"2016","journal-title":"Circ. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3892\/ijo.2014.2383","article-title":"Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo.","volume":"44","author":"Sekula","year":"2014","journal-title":"Int. J. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1161\/hc2301.092122","article-title":"Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.","volume":"103","author":"Shintani","year":"2001","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1172\/JCI30562","article-title":"The role of CXC chemokines in pulmonary fibrosis.","volume":"117","author":"Strieter","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/ATVBAHA.114.303579","article-title":"Stromal cell-derived factor 1 as a biomarker of heart failure and mortality risk.","volume":"34","author":"Subramanian","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001338","article-title":"Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.","volume":"4","author":"Tandon","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/CIRCRESAHA.110.227421","article-title":"Enhanced fibroblast-myocyte interactions in response to cardiac injury.","volume":"107","author":"Vasquez","year":"2010","journal-title":"Circ. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.107.716886","article-title":"Role of left ventricular stiffness in heart failure with normal ejection fraction.","volume":"117","author":"Westermann","year":"2008","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI17459","article-title":"Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.","volume":"111","author":"Yamamoto","year":"2003","journal-title":"J. Clin. Invest."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T05:08:12Z","timestamp":1550552892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":47,"alternative-id":["10.3389\/fphar.2019.00117"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00117","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"article-number":"117"}}